Labiotech.eu

News and Trends 21 Nov 2016

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

A new hope for HIV: a single antibody that can target nearly all viral strains at once. What does it mean for the search of a global cure? Last week, a research article in Cell Immunity reported a detailed study of an antibody that could neutralize 98% of HIV strains. The N6 antibody can also […]

November 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Nov 2016

Celyad’s Autologous CAR-T Therapy enters Phase Ib

Celyad has received approval to start Phase Ib trials in Belgium with its autologous CAR-T therapy, which can target 80% of tumors. After a successful Phase I in leukemia and myeloma, Celyad is ready to start a Phase Ib trial for its autologous NKR-2 in 7 cancer indications, now including solid tumors. The new trial, aimed to examine different […]

November 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

liver anatomy organs Sebastian Kaulitzki fi

News and Trends 21 Nov 2016

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

Promethera is collecting cash to fuel its liver disease program that revolves around HepaStem. I sat down with the CEO to hear more about the link between the company’s seemingly diverse interests and future direction. Promethera is the new kid on Belgium’s biotech block in Louvain-la-Neuve, and it’s hatching plans to make a splash with an IPO next spring. […]

November 21, 2016 - 7 minutesmins - By Evelyn Warner

News and Trends 19 Nov 2016

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

For any drug developer or service provider, cell line development is one of the most challenging phases, especially when subsequent GMP compliance is required. The need to secure good cell lines can, therefore, make all the difference in getting any biological to the market. The Swiss company Celonic has produced CHOvolution™, a cell line kit that allows you to […]

November 19, 2016 - 4 minutesmins - By Dani Bancroft

Screenshot 2016 11 18 at 4.09.17 PM e1479481859727

News and Trends 19 Nov 2016

Teaching Bacteria to make Living, Evolving Typography

Ori Elisar is an Israeli artist working on Biodesign. His globally-acclaimed project uses bacteria to create living typography that changes over time to represent the evolution of the Hebrew language. The Living Language project uses Paenibacillus vortex bacteria to create living typography. To represent the evolution of the Hebrew language, the artist makes bacteria grow […]

November 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Nov 2016

14 More Stories: CRISPR enters Humans, Biocartis makes a Splash

Try as we might, we can’t cover all the biotech news out there. During the week, we only pick the top stories to keep you informed but not waste your time. Here’s a roundup of news that didn’t make the cut this week. Biocartis had a big week. The molecular diagnostics company raised €32.7M in an equity […]

November 18, 2016 - 2 minutesmins - By Evelyn Warner

Screenshot 2016 11 18 at 11.23.36 AM e1479464682197

News and Trends 18 Nov 2016

These Spider Silk Sneakers from Adidas Are Biodegradable

Adidas just unveiled a biodegradable sneaker prototype made with a spider silk biomaterial manufactured by the German biotech AMSilk. Is this the beginning of a new era for sustainable biomaterials? AMSilk, located near Munich, is the world’s first biotech supplying synthetic silk biopolymers for textiles, cosmetics and medical devices. The company’s 100% biodegradable and vegan […]

November 18, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

antibiotic resistance biosensor freiburg

News and Trends 18 Nov 2016

Microfluidics and Biosensors to tackle Antibiotic Resistance

A little biosensor can analyze if there are antibiotics in your blood in 10 minutes. Developed by researchers from the University of Freiburg, the system could be used to develop a personalized course of antibiotics, but also to test food and water. The objective? Slow down the rise of multi-resistant bacteria. The World Antibiotic Awareness […]

November 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

Screenshot 2016 11 17 at 5.37.49 PM e1479400708474

News and Trends 18 Nov 2016

Can Oncolytic Viruses be the key to Treat Resistant Tumors?

This week, we leave Belgium and keep traveling north to Oslo, where snow is starting to pack for the joy of skiers. Meanwhile, Targovax is there working hard to treat cancer with its immunotherapy pipeline. City: Oslo, Norway Founded: 2010 Employees: 20 – 30 Financial data: €12M raised in a private placement in July Mission: Targovax develops immuno-oncology […]

November 18, 2016 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 17 Nov 2016

Boehringer’s Biosimilar could take a Chunk out of the Cancer Market

Boehringer Ingelheim is getting ready to launch a biosimilar for Roche’s cancer blockbuster Avastin as soon as the patent expires. Can it overcome the fierce competition in a market expected to grow to 50% of the drug market by 2020? Boehringer Ingelheim just announced results from a Phase I trial showing that its biosimilar candidate […]

November 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Nov 2016

Germany steps up the fight against the Most Painful Disease

Grünenthal just acquired Thar Pharmaceuticals to pave the way towards treating complex regional pain syndrome (CRPS), considered one of the most painful conditions. Grünenthal, the company behind the thalidomide scandal in the 60s due to childbirth deformities, is now focusing on complex regional pain syndrome (CRPS), a rare orphan disease that causes prolonged and intense pain. In order […]

November 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

card reading fate psychic Miriam Doerr Martin Frommherz fi

News and Trends 17 Nov 2016

What’s in the Cards for a Biosimilar after it Launches

As legal frameworks and regulatory pathways for biosimilars are in evolving all around the world, how will they affect the future of biosimilars? A biosimilar is a biological medicine that is similar to another already authorized for use, and they enter the market after the end of the patent of a biological drug. Biosimilars are […]

November 17, 2016 - 5 minutesmins - By External Contributor

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

Celyad’s Autologous CAR-T Therapy enters Phase Ib

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

Teaching Bacteria to make Living, Evolving Typography

14 More Stories: CRISPR enters Humans, Biocartis makes a Splash

These Spider Silk Sneakers from Adidas Are Biodegradable

Microfluidics and Biosensors to tackle Antibiotic Resistance

Can Oncolytic Viruses be the key to Treat Resistant Tumors?

Boehringer’s Biosimilar could take a Chunk out of the Cancer Market

Germany steps up the fight against the Most Painful Disease

What’s in the Cards for a Biosimilar after it Launches

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!